Image showing a PICO summary for:
Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party
by Gagelmann et al.
featured in the Stem Cell Evidence Alert - July 2025
From the #StemCellEvidence Alert:
Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party
by Gagelmann et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
12.08.2025 09:55 β π 0 π 0 π¬ 0 π 0
Image showing an extract of the Stem Cell Evidence Alert
The latest #StemCellEvidence monthly alert is out!
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
11.08.2025 06:13 β π 0 π 0 π¬ 0 π 0
Image showing a PICO summary for:
Phase 1/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCT
by Schulz et al.
featured in the Stem Cell Evidence Alert - June 2025
From the #StemCellEvidence Alert:
Phase 1/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCT
by Schulz et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
14.07.2025 14:52 β π 0 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A report from the CIBMTR
by Spellman et al.
featured in the Stem Cell Evidence Alert - June 2025
New from #StemCellEvidence:
Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A report from the CIBMTR
by Spellman et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
11.07.2025 08:24 β π 0 π 1 π¬ 0 π 0
New from #StemCellEvidence:
Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A report from the CIBMTR
by Spellman et al.
www.stemcellevidence.com/alerts/artic...
11.07.2025 08:23 β π 4 π 2 π¬ 0 π 0
Image showing a PICO summary for:
Effect of genetic mutations on outcomes of stem cell transplantation in children with hemophagocytic lymphohistiocytosis
by ΓztΓΌrk et al.
featured in the Stem Cell Evidence Alert - June 2025
From the #StemCellEvidence Alert:
Effect of genetic mutations on outcomes of stem cell transplantation in children with hemophagocytic lymphohistiocytosis
by ΓztΓΌrk et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
10.07.2025 12:56 β π 0 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Feasibility and efficacy of partial replacement of post transplantation cyclophosphamide with bendamustine on day +4 for graft versus host disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation
by Nair et al.
featured in the Stem Cell Evidence Alert - June 2025
New from #StemCellEvidence:
Feasibility and efficacy of partial replacement of post transplantation cyclophosphamide with bendamustine on day +4 for graft versus host disease prophylaxis (...)
by Nair et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
09.07.2025 09:21 β π 0 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis
by Mehta et al.
featured in the Stem Cell Evidence Alert - June 2025
From the #StemCellEvidence Alert:
Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis
by Mehta et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
08.07.2025 12:50 β π 1 π 2 π¬ 0 π 0
Image showing a PICO summary for:
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT
by Kawamura et al.
featured in the Stem Cell Evidence Alert - June 2025
New from #StemCellEvidence:
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT
by Kawamura et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
07.07.2025 10:07 β π 2 π 2 π¬ 0 π 0
Image showing a PICO summary for:
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the SociΓ©tΓ© Francophone de Greffe de Moelle et ThΓ©rapie Cellulaire (SFGM-TC)
by Chalandon et al.
featured in the Stem Cell Evidence Alert - June 2025
From the #StemCellEvidence Alert:
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study (...)
by Chalandon et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
04.07.2025 09:16 β π 0 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Comparison of Chimerism Kinetics and Associated Outcomes in Patients Receiving Post-Transplant Cyclophosphamide Versus Methotrexate based GVHD Prophylaxis Following Allogeneic Hematopoietic Cell Transplant
by Baranwal et al.
featured in the Stem Cell Evidence Alert - June 2025
New from #StemCellEvidence
Comparison of Chimerism Kinetics and Associated Outcomes in Patients Receiving Post-Transplant Cyclophosphamide Versus Methotrexate based GVHD Prophylaxis Following Allogeneic Hematopoietic Cell Transplant
by Baranwal et al
www.stemcellevidence.com/alerts/artic...
#MedSky
03.07.2025 11:50 β π 0 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Monogenic Inflammatory Bowel Disease
by Baccarella et al.
featured in the Stem Cell Evidence Alert - June 2025
From the #StemCellEvidence Alert:
Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Monogenic Inflammatory Bowel Disease
by Baccarella et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
02.07.2025 09:03 β π 0 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Darbepoetin, Red Cell Mass, and Neuroprotection in Preterm Infants: A Randomized Clinical Trial
by Ohls et al.
featured in the Transfusion Evidence Alert - June 2025
New from the #Transfusion Evidence Alert:
Darbepoetin, Red Cell Mass, and Neuroprotection in Preterm Infants: A Randomized Clinical Trial
by Ohls et al.
www.transfusionevidencelibrary.com/articles/403...
#MedSky
02.07.2025 08:50 β π 1 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD
by Habenicht et al.
featured in the Stem Cell Evidence Alert - June 2025
From the #StemCellEvidence Alert:
Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD
by Habenicht et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
01.07.2025 09:22 β π 1 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Liberal transfusion strategies reduce sepsis risk and improve neurological recovery in acute brain injury: an updated #systematicreview and #metaanalysis
by Nguyen et al.
featured in the Transfusion Evidence Alert - June 2025
New from the #Transfusion Evidence Alert:
Liberal transfusion strategies reduce sepsis risk and improve neurological recovery in acute brain injury: an updated #systematicreview and #metaanalysis
by Nguyen et al.
www.transfusionevidencelibrary.com/articles/403...
#MedSky
30.06.2025 10:20 β π 1 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A #systematicreview and #metaanalysis
by Sureda et al.
featured in the Stem Cell Evidence Alert - May 2025
New from the #StemCellEvidence Alert:
Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A #systematicreview and #metaanalysis
by Sureda et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
16.06.2025 12:23 β π 1 π 1 π¬ 0 π 0
Image showing a PICO summary for:
GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party
by Penack et al.
featured in the Stem Cell Evidence Alert - May 2025
From the #StemCellEvidence Alert:
GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party
by Penack et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
13.06.2025 12:02 β π 0 π 0 π¬ 0 π 0
Image showing a PICO summary for:
Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantation
by Nurse et al.
featured in the Stem Cell Evidence Alert - May 2025
New from the #StemCellEvidence Alert:
Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantation
by Nurse et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
12.06.2025 11:58 β π 0 π 1 π¬ 0 π 0
Image showing a PICO summary for:
How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation: A randomized multicentre feasibility trial
by New et al.
featured in the Transfusion Evidence Alert - May 2025
New from the #Transfusion Evidence Alert:
How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation (...)
by New et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
12.06.2025 11:41 β π 1 π 1 π¬ 0 π 0
Image showing a PICO summary for:
The Impact of Melphalan Conditioning and CD34+ Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis
by Muchtar et al.
featured in the Stem Cell Evidence Alert - May 2025
From the #StemCellEvidence Alert:
The Impact of Melphalan Conditioning and CD34+ Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis
by Muchtar et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
11.06.2025 09:00 β π 0 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular Therapy
by Michonneau et al.
featured in the Stem Cell Evidence Alert - May 2025
New from the #StemCellEvidence Alert:
Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis (...)
by Michonneau et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
10.06.2025 12:35 β π 0 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group
by MartΓnez et al.
featured in the Stem Cell Evidence Alert - May 2025
From the #StemCellEvidence Alert:
Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV (...)
by MartΓnez et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
09.06.2025 07:47 β π 1 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Examining the role of voluntary reciprocal altruism and collectivism interventions in enhancing intentions to donate blood among young non-donors: an experimental study
by Duffy and Molloy
featured in the Transfusion Evidence Alert - May 2025
From the #Transfusion Evidence Alert:
Examining the role of voluntary reciprocal altruism and collectivism interventions in enhancing intentions to donate blood among young non-donors: an experimental study
by Duffy and Molloy
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
09.06.2025 07:39 β π 2 π 1 π¬ 0 π 0
Image showing a PICO summary for:
GvHD prophylaxis with tacrolimus, sirolimus, and mycophenolate mofetil after reduced intensity conditioning hematopoietic stem cell allogeneic transplantation
by Lopez-Corral et al.
featured in the Stem Cell Evidence Alert - May 2025
New from the #StemCellEvidence Alert:
GvHD prophylaxis with tacrolimus, sirolimus, and mycophenolate mofetil after reduced intensity conditioning hematopoietic stem cell allogeneic transplantation
by Lopez-Corral et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
06.06.2025 08:17 β π 0 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program
by Horwitz et al.
featured in the Stem Cell Evidence Alert - May 2025
From the #StemCellEvidence Alert:
Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program
by Horwitz et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
05.06.2025 05:48 β π 0 π 0 π¬ 0 π 0
Image showing a PICO summary for:
#Systematicreview and #metaanalysis of intravenous iron therapy for patients with heart failure and iron deficiency
by Anker et al.
featured in the Transfusion Evidence Alert - May 2025
From the #Transfusion Evidence Alert:
#Systematicreview and #metaanalysis of intravenous iron therapy for patients with heart failure and iron deficiency
by Anker et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
05.06.2025 05:41 β π 1 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial
by Anker et al.
featured in the Transfusion Evidence Alert - May 2025
New from the #Transfusion Evidence Alert:
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial
by Anker et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
04.06.2025 07:25 β π 1 π 2 π¬ 0 π 0
Image showing a PICO summary for:
A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation
by Aubrey et al.
featured in the Stem Cell Evidence Alert - May 2025
New from the #StemCellEvidence Alert:
A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation
by Aubrey et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
04.06.2025 07:34 β π 1 π 1 π¬ 0 π 0
Image showing a PICO summary for:
Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis
by Hernandez-Boluda et al.
featured in the Stem Cell Evidence Alert - May 2025
From the #StemCellEvidence Alert:
Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis
by Hernandez-Boluda et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
03.06.2025 06:02 β π 0 π 1 π¬ 0 π 0
Image showing a PICO summary for:
The cost-effectiveness of interventions used for the screening, diagnosis and management of anaemia in pregnancy: A #systematicreview
by Allen et al.
featured in the Transfusion Evidence Alert - May 2025
From the #Transfusion Evidence Alert:
The cost-effectiveness of interventions used for the screening, diagnosis and management of anaemia in pregnancy: A #systematicreview
by Allen et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
03.06.2025 05:49 β π 2 π 2 π¬ 0 π 0
Cell Reprogramming in Hematopoiesis and Immunity, Lund University, Sweden. Tweets by Filipe Pereira (signed FP) and Malavika Nair (for Pereira lab). https://pereiralab.com/
Generating real world evidence in blood cancer using national NHS datasets.
A platform for life sciences. Publications, research protocols, news, events, jobs and more. Sign up at https://www.lifescience.net.
Global researcher & practitioner network based at The University of Queensland (UQ). Promotes donor research to health sector & community. Website: research.psy.uq.edu.au/dorn/
UQ Social Media Guidelines: http://bit.ly/3Cruuly
Co-Creating Ireland's Public Involvement in Open Research Roadmap
ENGAGED is building a national roadmap to shape public involvement in open research in Ireland. We believe that research can and does play an important role in tackling societal challenges.
Professor @ Oxford. We use zebrafish to study how cancer starts and spreads.
We fund cutting-edge scientific research across multiple Branches and Centers to better understand cancer and eliminate the suffering caused by the disease.
Development is a leading research journal in the field of developmental biology, covering stem cells, regeneration, evo-devo, epigenetics, morphogenesis and more. @biologists.bsky.social
Developmental biologist interested in cell specification and vascular biology.
Sir Henry Dale Fellow and Group Leader at the University of Oxford.
@idrm.ox.ac.uk | @oxforddpag.bsky.social | @ox.ac.uk
Head of the Cell and Tissue Mechanobiology Lab
@TheCrick, Lecturer @KingsCollegeLon| Previously #MooneyLab
@Harvard and @PCusachs Lab.
"Life starts from here. From now on is the good part"
BHF Fellow and Assistant Professor@Oxford. Developmental biology focused on blood vessels, passionate fan of enhancers and transcription factors, dabbles in zebrafish.
Translational Hematology Oncology Investigator, Roswell Park Comprehensive Cancer Center, Buffalo, NY
Hematologist, Oncologist, Physician Scientist
https://www.mskcc.org/cancer-care/doctors/urvi-shah
Penn Medicine - Abramson Cancer Center has proudly been an NCI-designated Comprehensive Cancer Center since 1973.
HematologyAdvisor.com is a trusted knowledge base of practical information and resources focused on hematology and critical care medicine.
This account is not actively posting follow us
@bloodjournals.hematology.org for the latest from Blood Journals Portfolio.
Pediatric Hematologist/Oncologist, Geneticist, Stem Cell Biologist
bloodgenes.org
Dad, Husband, Haematologist/Stem Cell transplanter, cook, reader, cycling to to get around (thus becoming passionate about city design) and enjoying amazing Auckland, Aotearoa New Zealand
MD PhD, Specialized in Multiple Myeloma. Memorial Sloan Kettering Cancer Center. Karolinska Institute. Posts/opinions are my own.